| DIRECT COMPETITOR COMPARISON | |
| SRLS | BIO | LIFE | MIL | Industry | | Market Cap: | 71.91M | 2.66B | 8.88B | 3.79B | 164.96M | | Employees: | N/A | 6,600 | 9,700 | 5,900 | 654 | | Qtrly Rev Growth (yoy): | 9.50% | 4.30% | 121.40% | 4.30% | 26.10% | | Revenue (ttm): | 44.43M | 1.74B | 2.95B | 1.63B | 233.16M | | Gross Margin (ttm): | 34.76% | 56.30% | 64.07% | 55.30% | 34.76% | | EBITDA (ttm): | 1.87M | 322.53M | 818.22M | 402.43M | 1.87M | | Oper Margins (ttm): | 1.37% | 13.00% | 15.72% | 16.93% | 13.70% | | Net Income (ttm): | -15.38M | 98.54M | 7.87M | 172.38M | N/A | | EPS (ttm): | -0.827 | 3.567 | 0.049 | 3.081 | N/A | | P/E (ttm): | N/A | 27.11 | 1015.92 | 22.10 | 21.39 | | PEG (5 yr expected): | N/A | 1.64 | 1.48 | 1.42 | 0.69 | | P/S (ttm): | 1.62 | 1.56 | 3.02 | 2.32 | 1.48 |
|
| BIO = Bio-Rad Laboratories, Inc. | | LIFE = Life Technologies Corporation | | MIL = Millipore Corp. | | Industry = Drugs - Generic | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.35 | -0.27% | 57.03B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.94 | 0.04% | 13.57B | 15.71 | | Genzyme Corp. | GENZ | 50.70 | -0.72% | 13.45B | 28.91 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.11 | -0.97% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.78 | -0.34% | 8.88B | 1015.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.79 | -0.17% | 46.51B | 48.30 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.09 | 0.35% | 3.94B | 19.12 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.83 | -1.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.87 | -0.78% | 5.46B | 109.63 | | Pfizer Inc. | PFE | 18.17 | -0.44% | 146.62B | 15.09 | | Johnson & Johnson | JNJ | 62.84 | -0.08% | 173.38B | 13.72 | | GlaxoSmithKline plc | GSK | 41.47 | -1.87% | 105.13B | 13.17 | | Sanofi-Aventis | SNY | 37.96 | -1.22% | 99.12B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.60 | 0.40% | 126.28B | 16.65 | | RHHBY.PK | 40.92 | -1.30% | N/A | N/A | | AstraZeneca plc | AZN | 44.83 | -1.02% | 65.00B | 9.00 | | Abbott Laboratories | ABT | 54.49 | 0.76% | 84.28B | 14.76 | | Bristol-Myers Squibb Co. | BMY | 25.31 | -0.28% | 50.14B | 13.09 |
|
| NEWS ON DIRECT COMPETITORS | |
| | LIFE | | Luminex Posts Loss Mon 10:14am -
Zacks.com | | | LIFE | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc. Wed, Nov 25 -
GlobeNewswire | | | BIO | | E-Bay veteran joins Elevation Partners as managing director Tue, Nov 24 -
at bizjournals.com | | | MIL | | MIL Buys Remaining Stake in India Tue, Nov 24 -
Zacks.com | | | MIL | | Millipore buys full stake in India joint venture Mon, Nov 23 -
AP | | | MIL | | Millipore Acquires Remaining Ownership of its Joint-Venture in India Mon, Nov 23 -
Business Wire | | | LIFE | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Fri, Nov 20 -
Wall Street Transcript | | | LIFE | | Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc. Thu, Nov 19 -
GlobeNewswire | | | BIO | | Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education Wed, Nov 18 -
PR Newswire | | | BIO | | Trading Outlook for Vermillion Inc. Issued by StockPreacher.com Mon, Nov 16 -
GlobeNewswire | | | BIO | | Zacks #1 Rank Additions for Monday Mon, Nov 16 -
Zacks.com | | | MIL | | MILLIPORE CORP /MA Financials Sat, Nov 14 -
EDGAR Online Financials | | | LIFE | | LIFE TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities Fri, Nov 13 -
EDGAR Online | | | LIFE | | Desktop Bug Detector Thu, Nov 12 -
at Forbes.com | | | MIL | | Millipore Corporation named Corporate Citizen of the Year Thu, Nov 12 -
Business Wire | | | MIL | | MILLIPORE CORP /MA Files SEC form 10-Q, Quarterly Report Tue, Nov 10 -
EDGAR Online | | | BIO | | BIO RAD LABORATORIES INC Financials Tue, Nov 10 -
EDGAR Online Financials | | | BIO | | Zacks #1 Rank Additions for Tuesday Tue, Nov 10 -
Zacks.com | | | BIO | | Coverage initiated on Bio-Rad Labs by Jefferies & Co Fri, Nov 6 -
Briefing.com | | | All Headlines for these symbols... |
|
|
|